Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Portillo’s Inc. Announces Offering of Class A Common Stock in “Synthetic Secondary” Transaction
-
ClearPoint Neuro Launches Proposed Public Offering of Common Stock
-
CymaBay Reports Fourth Quarter and Year Ended December 31, 2023 Financial Results and Provides Corporate Update
-
ThreeD Capital Inc. Amends Investor Relations Agreement
-
Change in Bigbank's 2024 financial calendar
-
GraniteShares Announces Forward Split of NVDL and FBL
-
Milestone Pharmaceuticals Announces Proposed Public Offering of Common Shares and Pre-Funded Warrants
-
Supernus to Participate in the TD Cowen 44th Annual Healthcare Conference
-
Interpublic Group to Present at the 2024 Morgan Stanley Technology, Media & Telecom Conference
-
UMH PROPERTIES, INC. REPORTS RESULTS FOR THE FOURTH QUARTER AND YEAR ENDED DECEMBER 31, 2023
-
Marathon Digital Holdings Reports Fourth Quarter and Fiscal Year 2023 Results
-
Aimfinity Investment Corp. I Announces Eighth Extension of the Deadline for an Initial Business Combination to March 28, 2024
-
Dycom Industries, Inc. to Participate in Upcoming Investor Conferences
-
Interpublic Group to Present at the 2024 Morgan Stanley Technology, Media & Telecom Conference
-
Premier Products Group Issues Shareholder Letter
-
Societal CDMO Enters Into Definitive Agreement to be Acquired by CoreRx, Inc.
-
Havila Kystruten AS: Fourth quarter 2023 accounts
-
Vera Therapeutics to Participate at the 44th Annual TD Cowen Health Care Conference
-
NL INDUSTRIES ANNOUNCES QUARTERLY DIVIDEND FOR THE FIRST QUARTER OF 2024 AT $.08 PER SHARE
-
NCLA Amicus Brief Asks U.S. Supreme Court to Reject NLRB-Specific Preliminary Injunction Standard
-
Aecon partnership executes contract to advance in-water works design for the Contrecœur Terminal Expansion project in Québec
-
COMPX ANNOUNCES INCREASE IN QUARTERLY DIVIDEND
-
Wintrust Financial Corporation to Present at RBC Capital Markets Global Financial Institutions Conference on March 5, 2024
-
Merus Announces Financial Results for the Fourth Quarter and Full Year 2023 and Provides Business Update
-
HP Inc. Reports Fiscal 2024 First Quarter Results
-
AdTheorent to Announce Fourth Quarter and Fiscal Year 2023 Financial Results on March 12, 2024
-
Quanex Building Products Declares Quarterly Dividend
-
Freehold Royalties Announces Fourth Quarter and Full Year 2023 Results, Reserves and Guidance for 2024
-
Oportun to Report Fourth Quarter 2023 Financial Results on Tuesday, March 12, 2024
-
Alpine Income Property Trust Announces Chief Financial Officer Transition
-
CTO Realty Growth Announces Chief Financial Officer Transition
-
Ninepoint Partners Announces First Closing of Ninepoint 2024 Short Duration Flow-Through Limited Partnership
-
Old National Bancorp to Present at the 2024 RBC Capital Markets Financial Institutions Conference
-
Compass Diversified Reports Fourth Quarter and Full Year 2023 Financial Results
-
COMPX REPORTS FOURTH QUARTER 2023 RESULTS
-
Royalty Pharma to Present at TD Cowen’s 44th Annual Health Care Conference
-
NeoGames Announces Fourth Quarter and Year-End 2023 Earnings Release Date
-
MYR Group Inc. Announces Fourth-Quarter and Full Year 2023 Results
-
Greif Reports First Quarter 2024 Results
-
Arcutis Announces Proposed Public Offering
-
ADMA Biologics Announces CFO Transition
-
Monster Beverage Reports 2023 Fourth Quarter and Full-Year Financial Results
-
Kiromic BioPharma to Present at the OTC Markets’ Virtual Life Science Investor Forum on March 7th
-
Altus Group Nominates Jim Hannon and Will Brennan to its Board of Directors
-
Orion Group Holdings Reports Fourth Quarter and Full Year 2023 Results
-
Shoals Technologies Group, Inc. Reports Financial Results for Fourth Quarter 2023
-
PetIQ, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
-
Merit Medical Introduces “Continued Growth Initiatives” Program and Financial Targets for Three-Year Period Ending December 31, 2026
-
Merit Medical Reports Results For Fourth Quarter and Year Ended December 31, 2023 - Issues Fiscal Year 2024 Guidance
-
Atea Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update


